Form 4: Unity Biotechnology CFO Lynne Marie Sullivan Sells Shares to Cover Tax Obligations

Lynne Marie Sullivan, CFO of Unity Biotechnology, sold 136 shares of common stock on November 4, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• On November 4, 2024, Lynne Marie Sullivan, the CFO and Head of Corporate Development of Unity Biotechnology, Inc. (UBX), sold 136 shares of the company's common stock.
• The sale was executed at a price of $1.29 per share.
• This transaction was conducted under a Rule 10b5-1 trading plan to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
• Following the transaction, Sullivan directly owns 55,925 shares, which includes RSUs that vest over time from the grant date.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing relates to a routine transaction for tax purposes and doesn't indicate a change in the company's fundamentals.

Industry Context

Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This particular filing indicates a sale of shares to cover tax obligations, which is a common practice.

Key Dates